Skip to main content
SpringerLink
Log in

Lung Cancer

  • Chapter
Tropical Hemato-Oncology

  • 745 Accesses

Abstract

Lung cancer remains the leading cause of cancer-related mortality in the developing world. Smoking is the most important preventable risk factor and strong public health efforts are needed to curtail this. Most patients with lung cancer have advanced disease at presentation; hence, the survival rates are poor. The role of screening low-dose CT for early detection of lung cancer has not been evaluated in the tropics and hence cannot be recommended in these areas. The standard of care for early-stage lung cancers remains surgical resection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ferlaly J, Soerjomataram I, Dikshit R et al (2015). Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136: E359–E386

    Google Scholar 

  2. Behera D, Balamugesh T (2004) Lung cancer in India. Indian J Chest Dis Allied Sci 46:269–281

    CAS  PubMed  Google Scholar 

  3. Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108

    Article  PubMed  Google Scholar 

  4. Janssen-Heijnen ML, Coebergh JW (2003) The changing epidemiology of lung cancer in Europe. Lung Cancer 41:245–258

    Article  PubMed  Google Scholar 

  5. Thun MJ, Lally CA, Flannery JT et al (1997) Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst 89:1580–1586

    Article  CAS  PubMed  Google Scholar 

  6. Bach PB, Kattan MW, Thornquist MD et al (2003) Variations in lung cancer risk among smokers. J Natl Cancer Inst 95:470–478

    Article  PubMed  Google Scholar 

  7. Lee PN, Forey BA (2013) Indirectly estimated absolute lung cancer mortality rates by smoking status and histological type based on a systematic review. BMC Cancer 13:189

    Article  PubMed Central  PubMed  Google Scholar 

  8. Prasad R, Singhal S, Garg R (2009) Bidi smoking and lung cancer. Biosci Trends 3:41–43

    PubMed  Google Scholar 

  9. Asomaning K, Miller DP, Liu G et al (2008) Second hand smoke, age of exposure and lung cancer risk. Lung Cancer 61:13–20

    Article  PubMed Central  PubMed  Google Scholar 

  10. Humans IWGotEoCRt (2010) Household use of solid fuels and high-temperature frying. IARC Monogr Eval Carcinog Risks Hum 95:1–430

    Google Scholar 

  11. Kurmi OP, Arya PH, Lam KB et al (2012) Lung cancer risk and solid fuel smoke exposure: a systematic review and meta-analysis. Eur Respir J 40:1228–1237

    Article  PubMed  Google Scholar 

  12. Yorifuji T, Kashima S (2013) Air pollution: another cause of lung cancer. Lancet Oncol 14:788–789

    Article  PubMed  Google Scholar 

  13. Groome PA, Bolejack V, Crowley JJ et al (2007) The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2:694–705

    Article  PubMed  Google Scholar 

  14. De Wever W, Stroobants S, Coolen J et al (2009) Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration. Eur Respir J 33:201–212

    Article  PubMed  Google Scholar 

  15. Annema JT, van Meerbeeck JP, Rintoul RC et al (2010) Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial. JAMA 304:2245–2252

    Article  CAS  PubMed  Google Scholar 

  16. Koike T, Yamato Y, Yoshiya K et al (2003) Intentional limited pulmonary resection for peripheral T1 N0 M0 small-sized lung cancer. J Thorac Cardiovasc Surg 125:924–928

    Article  PubMed  Google Scholar 

  17. Okada M, Koike T, Higashiyama M et al (2006) Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. J Thorac Cardiovasc Surg 132:769–775

    Article  PubMed  Google Scholar 

  18. Sugi K, Kaneda Y, Esato K (2000) Video-assisted thoracoscopic lobectomy achieves a satisfactory long-term prognosis in patients with clinical stage IA lung cancer. World J Surg 24:27–30; discussion 30–21

    Article  CAS  PubMed  Google Scholar 

  19. Strauss GM, Herndon JE 2nd, Maddaus MA et al (2008) Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol 26:5043–5051

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Timmerman RD, Herman J, Cho LC (2014) Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice. J Clin Oncol 32:2847–2854

    Article  PubMed  Google Scholar 

  21. Pignon JP, Tribodet H, Scagliotti GV et al (2008) Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 26:3552–3559

    Article  PubMed  Google Scholar 

  22. Ramnath N, Dilling TJ, Harris LJ et al (2013) Treatment of stage III non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143:e314S–e340S

    Article  CAS  PubMed  Google Scholar 

  23. Ardizzoni A, Boni L, Tiseo M et al (2007) Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis. J Natl Cancer Inst 99:847–857

    Article  CAS  PubMed  Google Scholar 

  24. Scagliotti GV, Parikh P, von Pawel J et al (2008) Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 26:3543–3551

    Article  CAS  PubMed  Google Scholar 

  25. Azzoli CG, Temin S, Aliff T et al (2011) 2011 Focused Update of 2009 American Society of clinical oncology clinical practice guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Clin Oncol 29:3825–3831

    Article  PubMed Central  PubMed  Google Scholar 

  26. Lima JP, dos Santos LV, Sasse EC et al (2010) Camptothecins compared with etoposide in combination with platinum analog in extensive stage small cell lung cancer: systematic review with meta-analysis. J Thorac Oncol 5:1986–1993

    Article  PubMed  Google Scholar 

  27. Prophylactic Cranial Irradiation Overview Collaborative Group (2000) Cranial irradiation for preventing brain metastases of small cell lung cancer in patients in complete remission. Cochrane Database Syst Rev (4):CD002805

    Google Scholar 

  28. Weksler B, Nason KS, Shende M et al (2012) Surgical resection should be considered for stage I and II small cell carcinoma of the lung. Ann Thorac Surg 94:889–893

    Article  PubMed  Google Scholar 

  29. Shi Y, Au JS, Thongprasert S et al (2014) A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER). J Thorac Oncol 9:154–162

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  30. Savas P, Hughes B, Solomon B (2013) Targeted therapy in lung cancer: IPASS and beyond, keeping abreast of the explosion of targeted therapies for lung cancer. J Thorac Dis 5:S579–S592

    PubMed Central  PubMed  Google Scholar 

  31. Solomon BJ, Mok T, Kim D-W, Wu Y-L et al (2014) First-line crizotinib versus chemotherapy in ALK-positive lung cancer. N Engl J Med 371:2167–2177

    Article  PubMed  Google Scholar 

  32. Shaw AT, Kim DW, Nakagawa K et al (2013) Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. N Engl J Med 368:2385–2394

    Article  CAS  PubMed  Google Scholar 

  33. Shaw AT, Ou S-H, Bang Y-J, Camidge DR et al (2014) Crizotinib in ROS1-rearranged non-small-cell lung cancer. N Engl J Med 371:1963–1971

    Article  PubMed Central  PubMed  Google Scholar 

  34. Soria JC, Mauguen A, Reck M et al (2013) Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer. Ann Oncol 24:20–30

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pulmonary Medicine, WHO Collaborating Centre for Research & Capacity Building in Chronic Respiratory Diseases, Postgraduate Institute of Medical Education & Research, Chandigarh, 160012, India

    Digamber Behera & V. Nagarjuna Maturu

Authors
  1. Digamber Behera
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. Nagarjuna Maturu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Digamber Behera .

Editor information

Editors and Affiliations

  1. Medical Oncology, Claude-Bernard-Lyon1 University, Lyon, France

    Jean-Pierre Droz

  2. Centre Hospitalier de Cayenne, Cayenne, French Guiana

    Bernard Carme

  3. Service de dermatologie, Centre hospitalier de Cayenne, Cayenne, French Guiana

    Pierre Couppié

  4. Guyane, INSERM CIC 1424, Centre d'Investigation Clinique Antilles, Centre Hospitalier de Cayenne, Cayenne, French Guiana

    Mathieu Nacher

  5. Service d’hémato-oncologie, Hôpital Saint-Louis, Paris, France

    Catherine Thiéblemont

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Behera, D., Maturu, V.N. (2015). Lung Cancer. In: Droz, JP., Carme, B., Couppié, P., Nacher, M., Thiéblemont, C. (eds) Tropical Hemato-Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-18257-5_37

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-18257-5_37

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-18256-8

  • Online ISBN: 978-3-319-18257-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation